Key result
HFrEF and HFmrEF show no significant difference in in-hospital mortality compared with HFpEF in ADHF.
Why the study?
Prior studies were inconsistent regarding the association between heart failure categorized by ejection fraction and mortality among patients with acute heart failure, particularly acute decompensated heart failure.
Does heart failure with reduced or mildly reduced ejection fraction increase the odds of in-hospital mortality compared to heart failure with preserved ejection fraction in patients hospitalized with acute decompensated heart failure?
Cohort (n=460)
Yes
Does heart failure with reduced or mildly reduced ejection fraction increase the odds of in-hospital mortality compared to heart failure with preserved ejection fraction in patients hospitalized with acute decompensated heart failure?
In a Filipino cohort of patients hospitalized with acute decompensated heart failure, HFrEF and HFmrEF showed a non-statistically significant trend toward higher in-hospital mortality compared to HFpEF, while COPD and higher heart rate were significantly associated with mortality.
Answers are grounded in this paper and cite their sources.
EF category not associated with in-hospital mortality in ADHF; leaves open prognostic value of HFrEF/HFmrEF and requires larger studies.
INTRODUCTION Ejection fraction (EF) is a powerful prognosticator for heart failure (HF). Acute heart failure (AHF) may either be new onset or acute decompensated heart failure (ADHF). Studies were inconsistent on the association of HF categorized by EF with mortality among AHF patients particularly ADHF. METHODS A retrospective cohort study of ADHF patients enrolled in the national Philippine Heart Association AHF registry was conducted. Patients with de novo HF were excluded. Binary logistic regression analysis was done. RESULTS From 1123 patients with AHF, 460 patients (41%) were diagnosed with ADHF. Heart failure reduced EF (HFrEF) was the most common classification (50%), followed by heart failure preserved EF (HFpEF 31%), and heart failure mildly reduced EF (HFmrEF 18%). The mean age was 56 years. Majority has no identifiable precipitating factors for decompensation. In-hospital mortality occurred in 11 patients (2.72%) with cardiovascular mortality as the major cause of death. On adjusted analysis, the odds of dying for HFrEF and HFmrEF was 7x (OR adj= 6.7; 95% CI 0.65-64.35) and 3x (OR adj=3.29 95% CI 0.15- 70.60) respectively compared to the odds of dying in HFpEF. However, this result was not statistically significant. CONCLUSION Although there was a trend for higher odds of dying for HFrEF and HFmrEF as compared to HFpEF, but the study did not show statistical significance.
No takes yet. Share an insight, caveat, or question.
Yaneza et al. (2026) conducted a cohort in Acute decompensated heart failure (ADHF) (n=460). Heart failure with reduced ejection fraction (HFrEF, EF ≤40%) and mildly reduced ejection fraction (HFmrEF, EF 41-49%) vs. Heart failure with preserved ejection fraction (HFpEF, EF ≥50%) was evaluated on In-hospital all-cause mortality (Adjusted OR 6.70, 95% CI 0.65-64.35, p=0.111). HFrEF (adjusted OR 6.70, 95% CI 0.65-64.35, p=0.111) and HFmrEF (adjusted OR 3.29, p=0.446) showed no statistically significant difference in in-hospital mortality compared to HFpEF in ADHF.
Synapse has enriched 10 related papers. Consider them for comparative context: